Alcoholic liver disease other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
Line 3: Line 3:
{{CMG}}
{{CMG}}
==Overview==
==Overview==
==Other Diagnostic Studies==
==Other Diagnostic Studies==
===Liver biopsy===
===Liver biopsy===

Revision as of 12:41, 28 October 2012

Alcoholic liver disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Alcoholic liver disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Alcoholic liver disease other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Alcoholic liver disease other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Alcoholic liver disease other diagnostic studies

CDC on Alcoholic liver disease other diagnostic studies

Alcoholic liver disease other diagnostic studies in the news

Blogs on Alcoholic liver disease other diagnostic studies

Directions to Hospitals Treating Alcoholic liver disease

Risk calculators and risk factors for Alcoholic liver disease other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Other Diagnostic Studies

Liver biopsy

2010 AASLD/ACG Alcoholic Liver Disease Guidelines : Biopsy (DO NOT EDIT)[1]

Class I
1. " For patients with a clinical diagnosis of severe alcoholic hepatitis (AH) for whom medical treatment is contemplated, or for those in whom reasonable uncertainty exists regarding the underlying diagnosis, a liver biopsy should be considered. This decision will depend on local expertise and ability in performing a liver biopsy in patients with coagulopathy, the patient’s severity of illness, and the type of therapy under consideration (Level of evidence: C) "

References

  1. "www.aasld.org" (PDF). Retrieved 2012-10-27.

Template:WH Template:WS